drugset / Trial / NCT01189097

Combined Therapy of Methadone and Dextromethrophan

NCT01189097

Phase 3 Unknown 1500 enrolled National Cheng-Kung University Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the pharmacological effects and outcomes of DM therapy with this add-on study. And to determine the immunological changes between the baseline and the end point of the study.

Timeline

Start
2008-04
Primary completion
2011-03
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Dextromethorphan Unknown 30 mg
Subject Dextromethorphan Unknown 60 mg
Subject Dextromethorphan Unknown 120 mg

Indications